NIH-funded research R01 grant

Investigating how a specific protein affects muscle function and diseases.

Official title: The role of nuclear envelope protein NET39 in skeletal muscle function and diseases

Funded at Ut Southwestern Medical Center · NIH-11013895 · Data updated 2026-11-12

This study is looking at a protein called NET39 to understand how changes in it can cause muscle diseases like Emery-Dreifuss muscular dystrophy, and it aims to find out more about why these muscle problems happen and how we might be able to treat them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$422,136
NIH project number5R01AR080676-03
Project IDNIH-11013895 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Emery-Dreifuss muscular dystrophy or related muscle disorders.

Less likely to help

Patients with muscle diseases not related to nuclear envelope proteins may not benefit from this research.

What this research studies

This research focuses on the role of a protein called NET39 in maintaining the structure and function of muscle cells. By studying how mutations in this protein lead to diseases like Emery-Dreifuss muscular dystrophy, the researchers aim to uncover the molecular mechanisms behind muscle-specific defects. The approach includes analyzing muscle biopsies from patients and using animal models to observe the effects of NET39 deletion. This could help clarify why certain muscle diseases occur and how they can be treated.

Why it matters

Potential benefit: If successful, this research could lead to new insights and potential treatments for muscle diseases caused by nuclear envelope protein mutations.

How similar studies have gone: Previous research has shown success in understanding muscle diseases related to nuclear envelope proteins, suggesting that this approach has potential for meaningful discoveries.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Olson, Eric N — Ut Southwestern Medical Center
  • Study coordinator: Olson, Eric N

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.